Condition: Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC) · Sponsor: Innoviva Specialty Therapeutics
The goal of this observational study is to evaluate the safety of sulbactam-durlobactam, as well as the risk of hypersensitivity reactions (including anaphylaxis) in participants with Acinetobacter baumannii-calcoaceticus complex infection. Participants will be followed for approximately 28 days in order to collect safety and reaction data.
This description comes directly from the study's public registry record.
Reddy Tummala ISTX Clinical Trials · 617-715-3600 · Clinicaltrials@istx.com
Always discuss trial participation with your own doctor first.
| UC Davis Health | Sacramento, California, United States | Recruiting |
| University of Florida - Gainesville | Gainesville, Florida, United States | Recruiting |
| Tampa General Hospital | Tampa, Florida, United States | Recruiting |
| University of Kansas Medical Center-Kansas City-3901 Rainbow Blvd | Kansas City, Kansas, United States | Recruiting |
| University of Kentucky College of Medicine | Lexington, Kentucky, United States | Recruiting |
| Ochsner Medical Center - New Orleans | New Orleans, Louisiana, United States | Recruiting |
| Ochsner LSU Health Science Center Shreveport | Shreveport, Louisiana, United States | Recruiting |
| Montefiore Medical Group Family Care Center | The Bronx, New York, United States | Recruiting |
| Summa Health System - Akron - 75 Arch Street | Akron, Ohio, United States | Recruiting |
| The Carl and Edyth Lindner Center for Research and Education at Christ Hospital | Cincinnati, Ohio, United States | Recruiting |
| University of Pittsburg School of Medicine | Pittsburgh, Pennsylvania, United States | Recruiting |
| Prisma Health - Infectious Diseases - Greenville | Greenville, South Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06746883